CARGO Therapeutics
Biotechnology ResearchView the employees at
CARGO Therapeutics-
Eric Liao Scientist I at CARGO Therapeutics
-
Millbrae, California, United States
-
Rising Star
Angela Haasch Results driven, self-motivated professional with solid experience supporting executives in a fast pace environment.-
San Mateo, California, United States
-
Top 5%
Beth Vasievich Head of Commercial Planning-
Boston, Massachusetts, United States
-
Rising Star
Luis Kidder-Heger Senior Manager Lab Operations-
Berkeley, California, United States
-
Rising Star
Overview
CARGO Therapeutics is engineering best-in-class CAR T-cell therapy to overcome resistance to cancer treatment and address barriers to access so that more patients may benefit from potentially curative therapies. CARGO is on a mission to outsmart cancer by advancing a new generation of best-in-class chimeric antigen receptor (CAR) T-cell therapies. Despite advances made by commercially available autologous CARs, these treatments are curative for fewer than half of all cancer patients. In addition, far too many patients are unable to access these potentially curative therapies due to other challenges, including manufacturing, supply constraints, slow turnaround time and reimbursement hurdles. The team at CARGO is intensely focused on pursuing novel solutions to achieve better cancer treatment outcomes and experiences.
-